NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 263 filers reported holding NEOGENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,091 | -23.9% | 34,235 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $553,515 | +91088.6% | 34,444 | -1.4% | 0.00% | -33.3% |
| Q1 2023 | $607 | +279.4% | 34,943 | +0.5% | 0.00% | +200.0% |
| Q4 2022 | $160 | -99.9% | 34,781 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $145,000 | +1015.4% | 34,395 | +1920.9% | 0.00% | – |
| Q2 2022 | $13,000 | +160.0% | 1,702 | +250.9% | 0.00% | – |
| Q1 2022 | $5,000 | -86.1% | 485 | -55.2% | 0.00% | – |
| Q4 2021 | $36,000 | +16.1% | 1,082 | +67.5% | 0.00% | – |
| Q3 2021 | $31,000 | +3.3% | 646 | -5.7% | 0.00% | – |
| Q2 2021 | $30,000 | +25.0% | 685 | +35.1% | 0.00% | – |
| Q1 2021 | $24,000 | +4.3% | 507 | +17.4% | 0.00% | – |
| Q4 2020 | $23,000 | +2200.0% | 432 | +953.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |